| 'Low risk'myelodysplastic syndrome (MDS) is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic Bcl-2 related proteins. JE Parker, KL Fishlock, A Mijovic, A Pagliuca, GJ Mufti BRITISH JOURNAL OF HAEMATOLOGY 101, 105-105, 1998 | | 1998 |
| ‘Low‐risk’myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐versus anti‐apoptotic bcl‐2‐related proteins Parker, Fishlock, Mijovic, Czepulkowski, Pagliuca, Mufti British journal of haematology 103 (4), 1075-1082, 1998 | 172 | 1998 |
| (B9) Childhood MDS in Turkey—clinical experience in 25 cases AM Tuncer, A Pagliuca, G Hicsonmez, GJ Mufti Leukemia Research 15, 5, 1991 | | 1991 |
| 18FDG-PET positron emission tomography (PET) is highly predictive of outcome following autograft for relapsed lymphoma. A retrospective study of 41 patients. P Fields, T Nunnan, S Devereaux, P Patten, A Ho, A Pagliuca, E Wegner, ... Blood 100 (11), 3042, 2002 | | 2002 |
| 265 Why have Pneumocystis carinii trophozoites been ignored? JMW Chatterton, AW L Joss, MM Davidson, D 0 Ho-Yen A Pagliuca, GJ Mufti, AN Baldwin, AJ Wallis, GE Wilson, A Curry, ... | | |
| 332 Outcomes of reduced intensity conditioning HSCT for lower-risk MDS: King's college hospital experience R Pinto, V Potter, V Tindell, P Krishnamurthy, J Marsh, R Ireland, ... Leukemia Research, S133, 2011 | | 2011 |
| 63 Long-term outcomes following RIC HSCT for MDS with fludarabine, busulphan and alemtuzumab V Potter, Z Lim, P Krishnamurthy, R Pinto, M Kenyon, J Marsh, R Ireland, ... Leukemia Research, S23, 2011 | | 2011 |
| A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia NH Russell, L Kjeldsen, C Craddock, A Pagliuca, JA Yin, RE Clark, ... Leukemia 29 (7), 1478-1484, 2015 | 46 | 2015 |
| A comparison of outcome for patients undergoing non-myeloablative stem cell transplantation compared to conventional conditioning for multiple myeloma HM Hunter, K Peggs, R Powles, J Apperley, P Mahendra, J Cavenagh, ... Blood 102 (11), 2705-, 2003 | 1 | 2003 |
| A Comparison of Stem Cell Source in Recipients of T-Cell Depleted Myeloablative Transplants for Leukaemia: No Difference in Mortality Using BM or PBSC. BE Shaw, NH Russell, A Pagliuca, J Apperley, G Cook, S Mackinnon, ... Blood, The Journal of the American Society of Hematology 110 (11), 46-46, 2007 | | 2007 |
| A Comprehensive Diagnostic Approach Improves the Diagnostic Accuracy of Invasive Fungal Disease (IFD) in Adult Haemato-Oncology Patients Undergoing HSCT or High Dose … MM Ceesay, L Berry, SR Desai, J Cleverely, C Kibbler, J Wade, M Smith, ... Blood 118 (21), 2972, 2011 | | 2011 |
| A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease in adult haemato-oncology patients undergoing HSCT or high-dose chemotherapy … MM Ceesay, L Berry, SR Desai, J Cleverly, CC Kibbler, J Wade, M Smith, ... BONE MARROW TRANSPLANTATION 47, S120-S120, 2012 | 2 | 2012 |
| A comprehensive diagnostic approach using galactomannan, targeted β‐d‐glucan, baseline computerized tomography and biopsy yields a significant burden of … MM Ceesay, SR Desai, L Berry, J Cleverley, CC Kibbler, S Pomplun, ... British Journal of Haematology 168 (2), 219-229, 2015 | 55 | 2015 |
| A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan … AYL Ho, P Krishnamurthy, ZY Lim, M Kenyon, A Mijovic, S Devereux, ... Blood 114 (22), 2266, 2009 | | 2009 |
| A Multicentre Retrospective UK Study Detailing Onset Of Graft Verus Host Disease, Responses To Treatment and Outcome After Donor Lymphocyte Infusion Following Haemopoietic Stem … JJ Scarisbrick, FL Dignan, S Tulpule, G Shah, A Pagliuca, R Malladi, ... Blood 122 (21), 4645, 2013 | | 2013 |
| A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequent JJ Scarisbrick, FL Dignan, S Tulpule, ED Gupta, S Kolade, B Shaw, ... Bone marrow transplantation 50 (1), 62-67, 2015 | 78 | 2015 |
| A national service for delivering CD19 CAR‐T in large B‐cell lymphoma–The UK real‐world experience A Kuhnl, C Roddie, AA Kirkwood, E Tholouli, T Menne, A Patel, C Besley, ... British Journal of Haematology 198 (3), 492-502, 2022 | 82 | 2022 |
| A phase 3, randomized, adaptive study of defibrotide (DF) vs best supportive care (BSC) for the prevention of hepatic veno-occlusive disease/sinusoidal obstruction syndrome … SA Grupp, S Corbacioglu, HJ Kang, T Teshima, M Zanette, P Lopez, ... Blood 138, 749, 2021 | 8 | 2021 |
| A Pooled Analysis of Survival By Defibrotide (DF) Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic … PG Richardson, E Carreras, A Pagliuca, RJ Ryan, W Tappe, M Mohty Biology of Blood and Marrow Transplantation 25 (3), S129-S130, 2019 | | 2019 |
| A Pooled Analysis of Survival By Defibrotide Timing of Initiation in Adults with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Following Hematopoietic Stem … P Richardson, E Carreras, A Pagliuca, R Ryan, W Tappe, M Mohty Blood 132, 815, 2018 | | 2018 |
